Approval on CBD sought

By Michelle Perrett

- Last updated on GMT

Mile High labs is seeking approval for its CBD isolate ingredient
Mile High labs is seeking approval for its CBD isolate ingredient

Related tags: regulations

Hemp derived cannabinoids (CBD) producer Mile High Labs has submitted a novel food application to the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA) for its CBD isolate ingredient and CBD isolate-based finished products.

In February, the FSA stated that all CBD products on the UK market must have a novel food application through the validation phase of the review process before 31 March 2021. Under the requirements, any CBD food products failing to gain regulatory approval would be taken off the shelves.

Its application includes information on the quality of the product, hemp biomass intake controls, stability data, manufacturing controls, labelling commitments, as well as testing requirements and specifications for CBD isolate and finished products.

Mile High Labs said it had also provided an assessment of the target population, a combined intake evaluation and toxicological data that supported the safe consumption of CBD.

Related topics: NPD

Related news

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us

Featured Events

View more

Products

View more

Webinars